We are live on
!
Find out more
PM
Parametrica Management Portfolio holdings
AUM
$88M
1-Year Est. Return
48.84%
This Fund
S&P 500
This Quarter
Est. Return
-4.28%
1 Year Est. Return
+48.84%
3 Year Est. Return
+257.17%
5 Year Est. Return
+315.15%
10 Year Est. Return
–
AUM
$27.9M
AUM Growth
+$12.7M
(+84%)
Cap. Flow
+$12.2M
Cap. Flow
% of AUM
43.59%
Top 10 Holdings %
Top 10 Hldgs %
17.59%
Holding
150
New
90
Increased
7
Reduced
6
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INSY
Insys Therapeutics, Inc.
INSY
|
+$637K |
| 2 |
Live Nation Entertainment
LYV
|
+$625K |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$462K |
| 4 |
Western Alliance Bancorporation
WAL
|
+$461K |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$460K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PTC Therapeutics
PTCT
|
+$519K |
| 2 |
TRCO
TRIBUNE MEDIA COMPANY CLASS A
TRCO
|
+$510K |
| 3 |
ESPR
Esperion Therapeutics
ESPR
|
+$443K |
| 4 |
Murphy USA
MUSA
|
+$440K |
| 5 |
DGI
DigitalGlobe Inc.
DGI
|
+$374K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.97% |
| 2 | Consumer Discretionary | 13.09% |
| 3 | Healthcare | 12.68% |
| 4 | Industrials | 11.61% |
| 5 | Financials | 10.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PAY
76
DELISTED
Verifone Systems Inc
PAY
| $213K | 0.76% |
+7,550
| New | +$187K |
|
77
UGI
UGI
$7.87B
| $211K | 0.76% |
+5,244
| New | +$190K |
|
|
BECN
78
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $211K | 0.76% |
+5,133
| New | +$195K |
|
|
WUBA
79
DELISTED
58.com Inc
WUBA
| $207K | 0.74% |
+3,725
| New | +$206K |
|
80
Marathon Petroleum
MPC
$90.1B
| $206K | 0.74% |
+5,541
| New | +$211K |
|
81
Alnylam Pharmaceuticals
ALNY
$38.3B
| $205K | 0.74% |
+3,259
| New | +$217K |
|
82
Archrock
AROC
$6.16B
| $205K | 0.74% |
+25,699
| New | +$143K |
|
|
POLY
83
DELISTED
Plantronics, Inc.
POLY
| $205K | 0.74% |
+5,238
| New | +$205K |
|
84
ScottsMiracle-Gro
SMG
$4.09B
| $204K | 0.73% |
+2,804
| New | +$191K |
|
|
B
85
DELISTED
Barnes Group Inc.
B
| $203K | 0.73% |
+5,782
| New | +$192K |
|
|
WBMD
86
DELISTED
WebMD Health Corp.
WBMD
| $203K | 0.73% |
+3,237
| New | +$173K |
|
87
Veeva Systems
VEEV
$33.8B
| $202K | 0.72% |
+8,085
| New | +$198K |
|
88
ServiceNow
NOW
$120B
| $201K | 0.72% |
+16,410
| New | +$208K |
|
89
ITT
ITT
$17.1B
| $200K | 0.72% |
+5,422
| New | +$185K |
|
|
ALJ
90
DELISTED
Alon USA Energy Inc
ALJ
| $200K | 0.72% |
+19,359
| New | +$219K |
|
|
TCF
91
DELISTED
TCF Financial Corporation
TCF
| $194K | 0.7% |
+15,834
| New | +$190K |
|
|
EPE
92
DELISTED
EP Energy Corporation
EPE
| $183K | 0.66% |
+40,662
| New | +$149K |
|
|
PKY
93
DELISTED
Parkway, Inc.
PKY
| $167K | 0.6% |
+10,675
| New | +$148K |
|
|
TIME
94
DELISTED
Time Inc.
TIME
| $157K | 0.56% |
10,151
-4,067
| -29% | -$58.5K |
|
95
Crocs
CROX
$6.63B
| $156K | 0.56% |
+16,166
| New | +$150K |
|
|
SC
96
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $125K | 0.45% |
+11,877
| New | +$131K |
|
|
MTOR
97
DELISTED
MERITOR, Inc.
MTOR
| $120K | 0.43% |
+14,940
| New | +$109K |
|
98
Novavax
NVAX
$1.21B
| $107K | 0.38% |
+1,040
| New | +$112K |
|
|
VTLE
99
DELISTED
Vital Energy
VTLE
| $95K | 0.34% |
+599
| New | +$81.4K |
|
|
UPL
100
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
| $88K | 0.32% |
176,652
+127,540
| +260% | +$151K |
|
Similar funds
BCP
PBCM
CVM
XXIP
DG
RFL
IAP
MPEM
Parametrica Management's Q1 2016 Portfolio in Review
As of Q1 2016, Parametrica Management held 150 positions worth $27.9M, up 84% from $15.2M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Parametrica Management deployed $12.2M of net new capital in Q1 2016, opening 90 new positions and adding to 7 existing holdings. Its largest new stake was Insys Therapeutics, Inc.: 33,562 shares worth $537K.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Finisar Corp, an estimated $315K trimmed.
- Parametrica Management's largest Q1 2016 buy was Insys Therapeutics, Inc.: 33,562 shares worth $537K.
- Parametrica Management added most to CNH Industrial in Q1 2016, an estimated $424K increase.
- Parametrica Management's biggest Q1 2016 reduction was Finisar Corp, cutting an estimated $315K.
- Parametrica Management fully exited PTC Therapeutics in Q1 2016, selling an estimated $519K.
- Parametrica Management's ten largest holdings make up 18% of its $27.9M portfolio in Q1 2016.
- Parametrica Management opened 90 new positions and closed 47 in Q1 2016.
- Parametrica Management's portfolio value rose 84% quarter-over-quarter to $27.9M.
Based on Parametrica Management's 13F filing for Q1 2016, filed 5 May 2016.